Standout Papers

<i>HER2</i> Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in <i>E... 2012 2026 2016 2021 549
  1. HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR -Mutant Lung Cancers That Lack the Second-Site EGFR T790M Mutation (2012)
    Ken Takezawa, Valentina Pirazzoli et al. Cancer Discovery

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 100 standout
Sub-graph 1 of 17

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
23 intermediate papers

Works of Greg J. Riely being referenced

1261MO Updated results from a phase I/II study of mobocertinib (TAK-788) in NSCLC with EGFR exon 20 insertions (exon20ins)
2020
HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR -Mutant Lung Cancers That Lack the Second-Site EGFR T790M Mutation
2012 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Greg J. Riely 657 552 150 350 13 789
Mary Ann Melnick 665 576 254 481 14 957
Tzu-Hsiu Chen 594 578 120 419 7 854
Graham Temple 429 438 85 287 16 710
Marcello Tiseo 630 494 207 410 9 863
José Rodrigues Pereira 605 529 163 410 15 889
Atsuko Ogino 661 520 175 487 18 896
Erin Larkins 418 608 154 271 26 881
Nishan Tchekmedyian 391 509 169 293 17 780
George Blumenschein 428 663 104 389 8 889
Renee Iacona 563 516 167 235 12 799

All Works

Loading papers...

Rankless by CCL
2026